We are live on
!
Find out more
FBB
Fulton Breakefield Broenniman Portfolio holdings
AUM
$1.53B
1-Year Est. Return
18.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.86%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$1.17B
AUM Growth
+$86.9M
(+8%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
29.24%
Holding
192
New
15
Increased
77
Reduced
68
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadridge
BR
|
+$6.44M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.02M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.74M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$1.62M |
| 5 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$8.28M |
| 2 |
Pfizer
PFE
|
+$5.49M |
| 3 |
GRMN
Garmin
GRMN
|
+$649K |
| 4 |
ServiceNow
NOW
|
+$579K |
| 5 |
Electronic Arts
EA
|
+$509K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.34% |
| 2 | Healthcare | 11.19% |
| 3 | Financials | 10.8% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Communication Services | 5.57% |
Similar funds
SG
FI
HR
MCP
CCM
CCP
ICM
GHC
Fulton Breakefield Broenniman's Q2 2021 Portfolio in Review
As of Q2 2021, Fulton Breakefield Broenniman held 192 positions worth $1.17B, up 8% from $1.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fulton Breakefield Broenniman's Q2 2021 filing shows 15 new, 77 increased, 68 reduced and 13 closed positions. Its largest new stake was Broadridge: 40,269 shares worth $6.5M. The largest sale was Eli Lilly, an estimated $8.28M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Fulton Breakefield Broenniman's largest Q2 2021 buy was Broadridge: 40,269 shares worth $6.5M.
- Fulton Breakefield Broenniman added most to iShares Core US Aggregate Bond ETF in Q2 2021, an estimated $2.02M increase.
- Fulton Breakefield Broenniman's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $8.28M.
- Fulton Breakefield Broenniman fully exited Garmin in Q2 2021, selling an estimated $649K.
- Fulton Breakefield Broenniman's ten largest holdings make up 29% of its $1.17B portfolio in Q2 2021.
- Fulton Breakefield Broenniman opened 15 new positions and closed 13 in Q2 2021.
- Fulton Breakefield Broenniman's portfolio value rose 8% quarter-over-quarter to $1.17B.
Based on Fulton Breakefield Broenniman's 13F filing for Q2 2021, filed 27 Jul 2021.